Biological Information

Background Information:

The L-type voltage-gated calcium channel is assayed on the FDA-preferred CiPA Protocol. Entry of extracellular Ca2+ through L-type Ca2+ channels is the trigger for cardiac muscle contraction via Ca2+-induced Ca2+ release from the sarcoplasmic reticulum. Concomitant block of other cardiac ion channels such as the L-type Ca2+ channel may reduce one of the substrates for Torsades de Pointes, increased QT dispersion (Antzelevitch, 2005a) that would result from hERG block alone (Antzelevitch, 2005a; Antzelevitch, 2004; Drouin et al., 1998). Furthermore concomitant block of L-type channels may suppress the essential trigger for Torsades de Pointes, early afterdepolarizations, caused by reactivation of Ca2+ current during phase 2/3 of the cardiac action potential (January and Riddle, 1989).

Family:

Ion Channel

Sub Family:

Calcium

Class:

Voltage-Gated

Organism:

Human

Cell Type:

HEK293

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Antagonist

Platform:

Qube®

Testing Information

Test Sample Requirements:

Minimum for 1) Screen: 100 μl of 300X stock based on the top concentration to be tested -OR- 2 mg (pre-weighed). 2) Dose Response: 100 μl of 300X stock based on the top concentration to be tested -OR- 2 mg (pre-weighed).

Minimum Order Quantity:

36

Turnaround Time

Standard:

25 Business Days

Service Scheduling Note:

This panel is run on a Monthly Schedule; PO and Compound Submission Form and Compound Receipt Deadlines are as follows: 5 Jan 2026, 2 Feb 2026, 2 Mar 2026, 6 Apr 2026, 4 May, 2026, 1 June, 2026, 6 July, 2026, 3 Aug 2026, 30 Aug 2026, 5 Oct 2026, 2 Nov, 2026, 1 Dec, 2026.

Additional Information

Brand:

IonChannelProfiler

Testing Location:

USA - St Charles, MO